Literature DB >> 24622636

Are colon and rectal surgeons ready to screen for anal dysplasia? Results of a survey on attitudes and practice.

Stephanie H Factor1, Amy Cooperstein, Guilherme A Pereira, Stephen E Goldstone.   

Abstract

BACKGROUND: Colorectal surgeons are ideal referral sources to screen for and treat high-grade anal dysplasia (high-grade squamous intraepithelial lesion [HSIL]) and anal cancer. Anal cytology and high-resolution anoscopy (HRA) using acetic acid and magnification are optimal methods for screening. We endeavored to determine US colorectal surgeons' attitudes and practices regarding HSIL screening.
METHODS: An Internet-based survey with questions related to clinician demographics and attitudes and practices regarding anal dysplasia was sent to US members of the American Society of Colon and Rectal Surgeons.
RESULTS: Of 1655 requests, 290 (18%) eligible participants responded. Most were white (83%), male (76%), board-certified colorectal surgeons (89%), and graduating medical school after 1990 (54%), almost all treated patients at risk for anal cancer and had read research on HSIL. Approximately one-third of respondents had performed anal cytology, and one-third had performed HRA. When evaluating patients for HSIL in surgery, only 31% use acetic acid with magnification. Of 99 participants who perform HRA, 46% were formally trained, 83% primarily do HRA primarily in the operating room, and 82% use acetic acid with magnification. Knowledge of HSIL risk factors was not associated with screening. Women, more recent graduates, and surgeons with higher percentages of HIV-infected patients were more likely to screen. Screening barriers included no training (52%), not a priority (23%), lack of evidence (21%), and cost (8%).
CONCLUSIONS: American Society of Colon and Rectal Surgeons members responding to the survey by and large do not screen for anal dysplasia. Those that do are often not formally trained and use inadequate technique.

Entities:  

Mesh:

Year:  2014        PMID: 24622636     DOI: 10.1097/OLQ.0000000000000105

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

Review 1.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

2.  High-resolution anoscopy: Unchartered territory for gastroenterologists?

Authors:  Andreia Albuquerque
Journal:  World J Gastrointest Endosc       Date:  2015-09-25

Review 3.  Anal squamous intraepithelial lesions: an update and proposed management algorithm.

Authors:  T Chittleborough; R Tapper; T Eglinton; Frank Frizelle
Journal:  Tech Coloproctol       Date:  2019-12-13       Impact factor: 3.781

4.  What Is the Risk of Anal Carcinoma in Patients With Anal Intraepithelial Neoplasia III?

Authors:  Grace C Lee; Hiroko Kunitake; Holly Milch; Lieba R Savitt; Caitlin E Stafford; Liliana G Bordeianou; Todd D Francone; Rocco Ricciardi
Journal:  Dis Colon Rectum       Date:  2018-12       Impact factor: 4.585

Review 5.  Background and Current Treatment of Squamous Cell Carcinoma of the Anus.

Authors:  Rob Glynne-Jones; Waqar Saleem; Mark Harrison; Suzy Mawdsley; Marcia Hall
Journal:  Oncol Ther       Date:  2016-08-01

6.  Anal Dysplasia in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men With Sexually Acquired Early Hepatitis C Virus Infection.

Authors:  Karen B Jacobson; Michael M Gaisa; Keith Sigel; Andrew L Foster; Daniel S Fierer
Journal:  Open Forum Infect Dis       Date:  2019-11-25       Impact factor: 3.835

7.  Screening with Anal Cytology in Colombia: Initial Experience and Need for High-Resolution Anoscopy.

Authors:  Kevin J Blair; Samuel Martínez-Vernaza; Ivonne Tatiana Ordóñez-Blanco; William Hernandez; Camilo Quiroga; Ellen Lowenstein; Sandra Liliana Valderrama-Beltrán; Jesse Clark; Jordan E Lake; Catherine Juillard; Luis Jorge Lombana Amaya
Journal:  J Surg Res       Date:  2021-06-30       Impact factor: 2.417

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.